Enzymes Industry Anticipated to Expand at 13.6% CAGR During the Forecast Period
Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Predicted Market Size Trajectory For The Enzymes Market From 2025 To 2034?
The size of the enzymes market has experienced swift expansion recently. Projections indicate a rise from $13.38 billion in 2024 to $15.2 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 13.6%. Historically, this expansion has been driven by factors such as globalization and market expansion, research and development investments, consumer awareness and demand, bioprocessing technology improvements, and waste reduction and recycling.
The enzymes market size is anticipated to experience swift expansion over the coming years. It is projected to reach “$25.34 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 13.6%. This projected growth during the forecast period stems from factors such as evolving market demand dynamics, a heightened emphasis on sustainable practices, prevailing health and nutrition trends, the rise of biofuel and renewable energy, and the emergence of new applications. Key developments anticipated in this period encompass advancements in biotechnology, increasing sustainability requirements, demand from the food and beverage sector, an broadening of industrial applications, and a consumer inclination towards natural products.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3425&type=smp
Which Drivers Are Impacting The Enzymes Market?
The escalating prevalence of digestive disorders is projected to propel the expansion of the enzyme market moving forward. Digestive disorders constitute a range of medical conditions impacting the digestive system. Common examples include gastroesophageal reflux disease (GERD), cancer, irritable bowel syndrome (IBS), lactose intolerance, hiatal hernia, and gallstones. Digestive enzymes are crucial for breaking down food into smaller molecules, enabling their absorption by the body. For instance, in October 2022, the National Center for Biotechnology Information (NCBI), a US-based resource for the scientific research community, reported that the prevalence of irritable bowel syndrome (IBS) in the United States lies between 10% and 15%, with nearly 12% of patients seeking medical care in primary care practices for IBS-related issues. Therefore, the growing incidence of digestive disorders is a key factor driving the growth of the enzyme market.
What Are The Primary Types Of Segments Analyzed In The Enzymes Market?
The enzymes market covered in this report is segmented –
1) By Product Type: Asparaginase, Lipase, Protease, Nattokinase, Chitinase, Serratiopeptidase, Collagenase, Ligase, Other Products
2) By Application: Leukemia, Stomach Disorders, Antitumor, Skin Ulcers, Gaucher Disease, Fabry Disease, Other Applications
3) By End User: Drug Manufacturers, Hospitals, Private Clinics, Research Laboratories
Subsegments:
1) By Asparaginase: L-asparaginase, Erwinia Asparaginase, Pegylated Asparaginase
2) By Lipase: Gastric Lipase, Pancreatic Lipase, Fungal Lipase, Bacterial Lipase
3) By Protease: Serine Proteases, Cysteine Proteases, Aspartic Proteases, Metalloproteases
4) By Nattokinase: Nattokinase Powder, Nattokinase Capsules
5) By Chitinase: Plant Chitinase, Microbial Chitinase
6) By Serratiopeptidase: Serratiopeptidase Tablets, Serratiopeptidase Capsules
7) By Collagenase: Type I Collagenase, Type II Collagenase, Type III Collagenase
8) By Ligase: DNA Ligase, RNA Ligase
9) By Other Products: Amylase, Cellulase, Beta-Glucanase, Other Specialty Enzymes
What Trends Are Expected To Drive The Enzymes Market?
Leading entities operating within the enzyme market are developing innovative products such as Lamzede to better serve patients. Lamzede (velmanase alfa) is a medication utilized for the treatment of alpha-mannosidosis, a rare genetic disorder caused by deficient activity of the lysosomal alpha-galactosidase-A enzyme. For instance, in May 2023, Chiesi Global Rare Diseases, a US-based pharmaceutical manufacturing company, received FDA approval for Lamzede (velmanase alfa) for the treatment of non-neurological symptoms in patients with mild-to-moderate alpha-mannosidosis. Lamzede is a recombinant form of human alpha-mannosidase developed in mammalian Chinese hamster ovary (CHO) cells using recombinant DNA technology. It stands as the first enzyme replacement therapy approved in the U.S. for addressing the non-central nervous system manifestations of alpha-mannosidosis.
Who Are The Prominent Global Companies Shaping The Enzymes Market?
Major companies operating in the enzymes market include Novozymes A/S, DuPont Industrial Biosciences, BASF SE, Koninklijke DSM N.V., Chr. Hansen Holding A/S, Roche Holding AG, Advanced Enzyme Technologies Ltd., AB Enzymes GmbH, Codexis Inc., Dyadic International Inc., Amano Enzyme Inc., Adisseo France SAS, Biocatalysts Ltd., Amano Enzyme Inc., Enzyme Development Corporation, Creative Enzymes, Hayashibara Co. Ltd., Thermo Fisher Scientific Inc., Associated British Foods Plc, Lonza Group AG, Novus International Inc., Epygen Biotech, DSM Nutritional Products AG, Soufflet Biotechnologies SAS, Beijing Leili Marine Bioindustry Inc., Jiangsu Boli Bioproducts Co. Ltd.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/enzyme-global-market-report
Which Global Regions Are Influencing The Competitive Landscape Of The Enzymes Market?
North America was the largest region in the enzymes market in 2024. The regions covered in the enzymes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Enzymes Market Report:
https://www.thebusinessresearchcompany.com/customise?id=3425&type=smp
Browse Through More Reports Similar to the Global Enzymes Market 2025, By The Business Research Company
Digestive Enzyme Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/digestive-enzyme-global-market-report
Specialty Enzyme Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/specialty-enzyme-global-market-report
Animal Growth Promoters And Performance Enhancers Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
